Stay updated on ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Sign up to get notified when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.

Latest updates to the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded a new Study Status entry to the study's record history on 2026-09-25, with a cross-reference to 2026-09-24 and the number 122. This documents an update to the study's current status within the history log.SummaryDifference0.1%

- Check15 days agoChange DetectedThe revision history now includes a new entry for Revision v3.7.0 and removes the previous entry v3.6.6, updating the page's version history.SummaryDifference0.0%

- Check36 days agoChange DetectedA new version entry (Revision: v3.6.6) dated 2026-08-28 was added to the history, and the previous revision (v3.6.5) was removed; this introduces an updated Study Status in the record timeline.SummaryDifference0.2%

- Check57 days agoChange DetectedThe record history adds a new revision entry v3.6.5 and removes the previous v3.6.4 entry, reflecting an update to the page's revision history.SummaryDifference0.0%

- Check72 days agoChange DetectedThe history now shows a new site revision (v3.6.4) replacing the previous revision (v3.6.3), indicating a recent software release for the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check86 days agoChange DetectedA new Study Status entry was added to the record history (noted on 2026-07-02 with 120 items) and an older entry dated 2026-06-05 was removed. This updates the visible history of the trial’s status and its historical record.SummaryDifference0.1%

Stay in the know with updates to ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.